157 related articles for article (PubMed ID: 26740553)
1. Integrating population variation and protein structural analysis to improve clinical interpretation of missense variation: application to the WD40 domain.
Laskowski RA; Tyagi N; Johnson D; Joss S; Kinning E; McWilliam C; Splitt M; Thornton JM; Firth HV; ; Wright CF
Hum Mol Genet; 2016 Mar; 25(5):927-35. PubMed ID: 26740553
[TBL] [Abstract][Full Text] [Related]
2. Pierpont syndrome associated with the p.Tyr446Cys missense mutation in TBL1XR1.
Slavotinek A; Pua H; Hodoglugil U; Abadie J; Shieh J; Van Ziffle J; Kvale M; Lee H; Kwok PY; Risch N; Sabbadini M
Eur J Med Genet; 2017 Oct; 60(10):504-508. PubMed ID: 28687524
[TBL] [Abstract][Full Text] [Related]
3. A specific mutation in TBL1XR1 causes Pierpont syndrome.
Heinen CA; Jongejan A; Watson PJ; Redeker B; Boelen A; Boudzovitch-Surovtseva O; Forzano F; Hordijk R; Kelley R; Olney AH; Pierpont ME; Schaefer GB; Stewart F; van Trotsenburg AS; Fliers E; Schwabe JW; Hennekam RC
J Med Genet; 2016 May; 53(5):330-7. PubMed ID: 26769062
[TBL] [Abstract][Full Text] [Related]
4. TBLR1 regulates the expression of nuclear hormone receptor co-repressors.
Zhang XM; Chang Q; Zeng L; Gu J; Brown S; Basch RS
BMC Cell Biol; 2006 Aug; 7():31. PubMed ID: 16893456
[TBL] [Abstract][Full Text] [Related]
5. Prospective investigation of FOXP1 syndrome.
Siper PM; De Rubeis S; Trelles MDP; Durkin A; Di Marino D; Muratet F; Frank Y; Lozano R; Eichler EE; Kelly M; Beighley J; Gerdts J; Wallace AS; Mefford HC; Bernier RA; Kolevzon A; Buxbaum JD
Mol Autism; 2017; 8():57. PubMed ID: 29090079
[TBL] [Abstract][Full Text] [Related]
6. Structure of the MeCP2-TBLR1 complex reveals a molecular basis for Rett syndrome and related disorders.
Kruusvee V; Lyst MJ; Taylor C; Tarnauskaitė Ž; Bird AP; Cook AG
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3243-E3250. PubMed ID: 28348241
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
[TBL] [Abstract][Full Text] [Related]
8. TBL1XR1 associated intellectual disability, a new missense variant with dysmorphic features plus autism: Expanding the phenotypic spectrum.
Arroyo Carrera I; Fernández-Burriel M; Lapunzina P; Tenorio JA; García Navas VD; Márquez Isidro E
Clin Genet; 2021 Jun; 99(6):812-817. PubMed ID: 33527360
[TBL] [Abstract][Full Text] [Related]
9. De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity.
Nishi A; Numata S; Tajima A; Zhu X; Ito K; Saito A; Kato Y; Kinoshita M; Shimodera S; Ono S; Ochi S; Imamura A; Kurotaki N; Ueno SI; Iwata N; Fukui K; Imoto I; Kamiya A; Ohmori T
Sci Rep; 2017 Jun; 7(1):2887. PubMed ID: 28588275
[TBL] [Abstract][Full Text] [Related]
10. De Novo Missense Variants in WDR37 Cause a Severe Multisystemic Syndrome.
Reis LM; Sorokina EA; Thompson S; Muheisen S; Velinov M; Zamora C; Aylsworth AS; Semina EV
Am J Hum Genet; 2019 Aug; 105(2):425-433. PubMed ID: 31327510
[TBL] [Abstract][Full Text] [Related]
11. Novel KDM5B splice variants identified in patients with developmental disorders: Functional consequences.
Lebrun N; Mehler-Jacob C; Poirier K; Zordan C; Lacombe D; Carion N; Billuart P; Bienvenu T
Gene; 2018 Dec; 679():305-313. PubMed ID: 30217758
[TBL] [Abstract][Full Text] [Related]
12. A homozygous potentially pathogenic variant in the PAXBP1 gene in a large family with global developmental delay and myopathic hypotonia.
Alharby E; Albalawi AM; Nasir A; Alhijji SA; Mahmood A; Ramzan K; Abdusamad F; Aljohani A; Abdelsalam O; Eldardear A; Basit S
Clin Genet; 2017 Dec; 92(6):579-586. PubMed ID: 28542722
[TBL] [Abstract][Full Text] [Related]
13. De novo deletion of TBL1XR1 in a child with non-specific developmental delay supports its implication in intellectual disability.
Tabet AC; Leroy C; Dupont C; Serrano E; Hernandez K; Gallard J; Pouvreau N; Gadisseux JF; Benzacken B; Verloes A
Am J Med Genet A; 2014 Sep; 164A(9):2335-7. PubMed ID: 24891185
[TBL] [Abstract][Full Text] [Related]
14. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
15. A novel de novo pathogenic variant in TBL1XR1 as a new proposed cause of Pierpont syndrome.
Tamma PL; Streff H; Murali CN
Am J Med Genet A; 2023 Jun; 191(6):1576-1580. PubMed ID: 36843287
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a recurrent missense mutation in the forkhead DNA-binding domain of FOXP1.
Johnson TB; Mechels K; Anderson RH; Cain JT; Sturdevant DA; Braddock S; Pinz H; Wilson MA; Landsverk M; Roux KJ; Weimer JM
Sci Rep; 2018 Nov; 8(1):16161. PubMed ID: 30385778
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha.
Burke LJ; Downes M; Laudet V; Muscat GE
Mol Endocrinol; 1998 Feb; 12(2):248-62. PubMed ID: 9482666
[TBL] [Abstract][Full Text] [Related]
18. Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans.
Lohmann K; Masuho I; Patil DN; Baumann H; Hebert E; Steinrücke S; Trujillano D; Skamangas NK; Dobricic V; Hüning I; Gillessen-Kaesbach G; Westenberger A; Savic-Pavicevic D; Münchau A; Oprea G; Klein C; Rolfs A; Martemyanov KA
Hum Mol Genet; 2017 Mar; 26(6):1078-1086. PubMed ID: 28087732
[TBL] [Abstract][Full Text] [Related]
19. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
Xu HE; Stanley TB; Montana VG; Lambert MH; Shearer BG; Cobb JE; McKee DD; Galardi CM; Plunket KD; Nolte RT; Parks DJ; Moore JT; Kliewer SA; Willson TM; Stimmel JB
Nature; 2002 Feb; 415(6873):813-7. PubMed ID: 11845213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
